Pharmaceutical group

Alkem

21 medicines1 country

A group of 5 companies with 21 medicines in 1 country.

Its medicines

Group structure

5 companies in 1 country

India1

Alkem Laboratories LimitedAuthorisation holder · 1 medicine

Headquarters not stated4

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine of every company in the group, current ones first.

21 medicines

Medicine	Substance	Country	Status	Authorised
AZILSARTAN MEDOXOMIL AND CHLORTHALIDONE40mg medoxomil; 12.5mg \| 40mg medoxomil; 25mg · Tablet	Azilsartan kamedoxomil, Chlorthalidone	United States	Marketed	2025
CEFIXIME400mg · Capsule	Cefixime	United States	Marketed	2018
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE5mg; 2.5mg · Capsule	Chlordiazepoxide, Clidinium	United States	Marketed	2020
COLESEVELAM HYDROCHLORIDE625mg · Tablet	Colesevelam	United States	Marketed	2018
ENALAPRIL MALEATE1mg/ml · Solution	Enalapril	United States	Marketed	2021
MARINOL10mg \| 2.5mg \| 5mg · Capsule	Dronabinol	United States	Marketed	1985
MESALAMINE250mg \| 375mg \| 500mg · Capsule, extended release	Mesalazine	United States	Marketed	2019
MIRABEGRON8mg/ml · For suspension, extended release	Mirabegron	United States	Marketed	2026
MYCOPHENOLATE MOFETIL200mg/ml · For suspension	Mycophenolate mofetil	United States	Marketed	2014
NEBIVOLOL HYDROCHLORIDE10mg \| 10mg base \| 2.5mg \| 2.5mg base \| 20mg \| 20mg base \| 5mg \| 5mg base · Tablet	Nebivolol	United States	Marketed	2015
NIMODIPINE3mg/ml \| 60mg/10ml \| 6mg/ml · Solution	Nimodipine	United States	Marketed	2024
RILUZOLE50mg/10ml · Suspension	Riluzole	United States	Marketed	2024
ROFLUMILAST250mcg \| 500mcg · Tablet	Roflumilast	United States	Marketed	2018
SIROLIMUS0.5mg \| 1mg \| 2mg · Tablet	Sirolimus	United States	Marketed	2014
SITAGLIPTIN PHOSPHATE100mg \| 100mg base \| 25mg \| 25mg base \| 50mg \| 50mg base · Tablet	Sitagliptin	United States	Marketed	2012
TOLVAPTAN15mg \| 30mg \| 45mg \| 60mg \| 90mg · Tablet	Tolvaptan	United States	Marketed	2020
TOPIRAMATE25mg/ml · Solution	Topiramate	United States	Marketed	2024
VANCOMYCIN HYDROCHLORIDE250mg base/5ml \| 25mg base/ml \| 50mg base/ml · For solution	Vancomycin	United States	Marketed	2022
BEMPEDOIC ACID AND EZETIMIBE180mg · Tablet	Bempedoic acid, Ezetimiba	United States	tentative	2025
SODIUM ZIRCONIUM CYCLOSILICATE10G · Powder, for suspension	Sodium zirconium cyclosilicate	United States	tentative	2025
TAPENTADOL100mg \| 50mg \| 75mg · Tablet	Tapentadol	United States	tentative	2015

Sources and licences

Country	Medicines	Current	Past	Companies
United States	21	18	3	Companies All medicines

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Anvisa, Brazil

Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.

Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions

INVIMA

Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.

Licence: CC BY-SA 4.0

INVIMA

Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.

Licence: CC BY-SA 4.0

Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA)

Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.

Licence: CC BY-SA 4.0

Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA)

Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes, dataset i7cb-raxc, rowsUpdatedAt 1792152574, acquired 2026-10-26; original values retained.

Licence: CC BY-SA 4.0

All 8 sources

National Pharmaceutical Regulatory Agency / Ministry of Health Malaysia

National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.

Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication

Läkemedelsverket, Sweden

Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.

Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)

Report an error or request removal Corrections from the company itself are welcome.

Alkem

Group structure

India1

Headquarters not stated4

Medicines

Know your medicines, with the sources.

Alkem

Group structure

India1

Headquarters not stated4

Medicines

Know your medicines, with the sources.

Countries

Top substances

Names in the registers

Sources and licences

At a glance

Work with Prognia

Other big groups

Group structure

🇮🇳India1

Headquarters not stated4

Medicines

Know your medicines, with the sources.

Group structure

🇮🇳India1

Headquarters not stated4

Medicines

Know your medicines, with the sources.

Countries

Top substances

Names in the registers

Sources and licences

At a glance

Work with Prognia

India1

India1